Michael Mohning
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cough | 2 | 2015 | 107 | 0.900 |
Why?
| Dyspnea | 2 | 2015 | 211 | 0.840 |
Why?
| Acute Lung Injury | 3 | 2017 | 298 | 0.660 |
Why?
| c-Mer Tyrosine Kinase | 1 | 2017 | 43 | 0.580 |
Why?
| Cell-Derived Microparticles | 1 | 2017 | 57 | 0.550 |
Why?
| Phagocytosis | 1 | 2017 | 350 | 0.510 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 226 | 0.500 |
Why?
| Macrophages, Alveolar | 1 | 2017 | 347 | 0.470 |
Why?
| Proto-Oncogene Proteins | 1 | 2017 | 608 | 0.450 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 505 | 0.420 |
Why?
| Tomography, X-Ray Computed | 2 | 2019 | 2285 | 0.400 |
Why?
| Lung | 4 | 2019 | 3559 | 0.370 |
Why?
| Lung Diseases, Interstitial | 1 | 2014 | 508 | 0.320 |
Why?
| Alveolitis, Extrinsic Allergic | 2 | 2019 | 86 | 0.310 |
Why?
| Inflammation | 1 | 2017 | 2478 | 0.280 |
Why?
| Diagnosis, Differential | 2 | 2019 | 1342 | 0.210 |
Why?
| Asthma | 1 | 2015 | 2029 | 0.200 |
Why?
| Macrophages | 2 | 2018 | 1261 | 0.180 |
Why?
| Radiologists | 1 | 2019 | 35 | 0.160 |
Why?
| Bleomycin | 2 | 2018 | 228 | 0.160 |
Why?
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 63 | 0.160 |
Why?
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.150 |
Why?
| CD11 Antigens | 1 | 2018 | 30 | 0.150 |
Why?
| Mortality | 1 | 2019 | 287 | 0.140 |
Why?
| Cause of Death | 1 | 2019 | 361 | 0.140 |
Why?
| CD11b Antigen | 1 | 2016 | 57 | 0.130 |
Why?
| Gene Deletion | 1 | 2018 | 356 | 0.130 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 53 | 0.130 |
Why?
| Mice, Inbred C57BL | 4 | 2017 | 4692 | 0.130 |
Why?
| Phagocytes | 1 | 2016 | 90 | 0.130 |
Why?
| Auscultation | 1 | 2015 | 4 | 0.120 |
Why?
| Pulmonary Fibrosis | 1 | 2018 | 323 | 0.120 |
Why?
| Radiography, Thoracic | 1 | 2015 | 150 | 0.110 |
Why?
| Antigens, CD | 1 | 2016 | 442 | 0.110 |
Why?
| Neovascularization, Physiologic | 1 | 2014 | 173 | 0.110 |
Why?
| Regeneration | 1 | 2014 | 160 | 0.100 |
Why?
| Mice, Knockout | 1 | 2017 | 2568 | 0.090 |
Why?
| Apoptosis | 1 | 2017 | 2362 | 0.080 |
Why?
| Severity of Illness Index | 1 | 2015 | 2537 | 0.070 |
Why?
| Animals | 7 | 2018 | 31698 | 0.070 |
Why?
| Middle Aged | 3 | 2019 | 26732 | 0.070 |
Why?
| Mice | 4 | 2018 | 14863 | 0.070 |
Why?
| Male | 5 | 2019 | 55579 | 0.060 |
Why?
| Adenoviridae Infections | 1 | 2005 | 15 | 0.060 |
Why?
| Enterotoxins | 1 | 2005 | 88 | 0.060 |
Why?
| Signal Transduction | 1 | 2017 | 4512 | 0.060 |
Why?
| Humans | 6 | 2019 | 114654 | 0.060 |
Why?
| Intracellular Fluid | 1 | 2003 | 27 | 0.060 |
Why?
| Interleukin-4 | 1 | 2003 | 206 | 0.050 |
Why?
| Th2 Cells | 1 | 2003 | 154 | 0.050 |
Why?
| Adjuvants, Immunologic | 1 | 2003 | 206 | 0.050 |
Why?
| Sulfhydryl Compounds | 1 | 2003 | 177 | 0.050 |
Why?
| Pneumonia | 2 | 2017 | 567 | 0.050 |
Why?
| Female | 6 | 2019 | 59488 | 0.050 |
Why?
| Occupations | 1 | 2019 | 36 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2003 | 591 | 0.040 |
Why?
| Forecasting | 1 | 2019 | 330 | 0.040 |
Why?
| Mice, Transgenic | 2 | 2016 | 1947 | 0.030 |
Why?
| Cell Lineage | 1 | 2017 | 309 | 0.030 |
Why?
| Organ Specificity | 1 | 2016 | 268 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 385 | 0.030 |
Why?
| Cytokines | 2 | 2017 | 1840 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2017 | 477 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2016 | 337 | 0.030 |
Why?
| Endothelium | 1 | 2014 | 110 | 0.030 |
Why?
| United States | 2 | 2019 | 12179 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 821 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 521 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2005 | 1143 | 0.020 |
Why?
| Interferon-gamma | 2 | 2005 | 719 | 0.020 |
Why?
| Gene Expression | 1 | 2016 | 1421 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1518 | 0.020 |
Why?
| Flow Cytometry | 1 | 2014 | 1083 | 0.020 |
Why?
| Cell Proliferation | 1 | 2017 | 2186 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2017 | 2762 | 0.020 |
Why?
| Splenomegaly | 1 | 2005 | 17 | 0.020 |
Why?
| Mice, Inbred DBA | 1 | 2005 | 173 | 0.020 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2005 | 88 | 0.020 |
Why?
| Alanine Transaminase | 1 | 2005 | 141 | 0.010 |
Why?
| Interphase | 1 | 2003 | 32 | 0.010 |
Why?
| STAT6 Transcription Factor | 1 | 2003 | 22 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 309 | 0.010 |
Why?
| CD3 Complex | 1 | 2003 | 92 | 0.010 |
Why?
| Transcription Factor AP-1 | 1 | 2003 | 80 | 0.010 |
Why?
| Active Transport, Cell Nucleus | 1 | 2003 | 110 | 0.010 |
Why?
| NFATC Transcription Factors | 1 | 2003 | 78 | 0.010 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 150 | 0.010 |
Why?
| Interleukin-12 | 1 | 2003 | 110 | 0.010 |
Why?
| Solubility | 1 | 2003 | 223 | 0.010 |
Why?
| Th1 Cells | 1 | 2003 | 123 | 0.010 |
Why?
| Drug Combinations | 1 | 2003 | 287 | 0.010 |
Why?
| Acetylcysteine | 1 | 2003 | 141 | 0.010 |
Why?
| Spleen | 1 | 2003 | 487 | 0.010 |
Why?
| Down-Regulation | 1 | 2003 | 594 | 0.010 |
Why?
| Trans-Activators | 1 | 2003 | 367 | 0.010 |
Why?
| Cell Nucleus | 1 | 2003 | 554 | 0.010 |
Why?
| Up-Regulation | 1 | 2003 | 807 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1139 | 0.010 |
Why?
| Lymphocyte Activation | 1 | 2003 | 1037 | 0.010 |
Why?
| Liver | 1 | 2005 | 1637 | 0.010 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1314 | 0.010 |
Why?
| Cells, Cultured | 1 | 2003 | 3885 | 0.010 |
Why?
| Transcription Factors | 1 | 2003 | 1528 | 0.010 |
Why?
|
|
Mohning's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|